ArticleEJNMMI physics2025
Diagnostic CT organ dose estimation in whole-body PET/CT examinations-comparison of a patient-specific monte carlo approach and a computational phantom-based CT dosimetry tool.
Article in EJNMMI physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundStudies evaluating the impact of advances in CT dosimetry tools on CT organ dose estimations are often limited to a comparison with TLD measurements in anthropomorphic phantoms or a comparison of different dosimetry tools using computational phantoms and CT examinations performed at radiology departments. This study evaluates organ dose estimations obtained using a patient-specific Monte Carlo simulation and a computational phantom-based dosimetry tool for whole-body PET/CT examinations. In addition, the correlation of organ doses with the size-specific dose estimate (SSDE) was investigated.
methodsUsing the Monte Carlo software ImpactMC, patient-specific organ doses were simulated in 100 adult patients using whole-body CT scans acquired on a Siemens Biograph mCT Flow and a GE Discovery MI PET/CT. For each patient, organ doses were also estimated using the computational phantom-based dosimetry tool NCICT. Absolute and normalised to CTDI
resultsThe average percentage difference of NCICT to ImpactMC organ doses across all organs and BMI categories for whole-body examinations performed with TCM was - 5% and - 22% for the Siemens and GE PET/CT, respectively. Strong variations are observed between patients. Depending on the organ of interest, NCICT under-or overestimates the organ dose. Nevertheless, depending on the PET/CT system, moderate to excellent agreement was found between organ doses estimated with NCICT and ImpactMC. No correlations were observed between the obtained organ dose differences and patient length (R
conclusionCompared to the patient-specific Monte Carlo CT dosimetry software ImpactMC, the computational phantom-based dosimetry tool NCICT could provide organ dose estimates within ± 22% for whole-body CT scans acquired with TCM. If better accuracies are required, patient-specific Monte Carlo simulations are recommended. Depending on the organ of interest and the specific CT scanner, SSDE may be a good first estimate of the organ dose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.